𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia

✍ Scribed by G. Tertian; J. Cartron; C. Bayle; A. Rudent; T. Lambert; G. Tchernia


Publisher
Springer
Year
1996
Tongue
English
Weight
99 KB
Volume
38
Category
Article
ISSN
1269-3286

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Rituximab therapy for chronic lymphocyti
✍ Giovanni D'Arena; Luca Laurenti; Silvana Capalbo; Alfonso Maria D'Arco; Rosaria πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

Autoimmune hemolytic anemia (AIHA) is a well-known complication of chronic lymphocytic leukemia (CLL). In recent years the anti-CD20 monoclonal antibody rituximab has been used for the therapy of steroid-refractory AIHA and autoimmune thrombocytopenia, either idiopathic or in association with CLL. W